Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project (original) (raw)

Patients' Perception on Doctor -Pharmacist Collaborative Practice In Medical Care

Patient care is a complex activity demanding cooperative work between health and social care professionals for optimal outcomes. Patient satisfaction is a yardstick for measuring quality of care and has become a standard part of evaluation of healthcare system. The study intends to find out the patients' level of satisfaction with care received and their perception of doctor-pharmacist collaboration. The study is a survey using questionnaires to determine the attitudes and expectations of patients that consented to take part in the research. The data obtained were computed and analyzed using a computer based analytical software. A descriptive statistics of the responses showed consensus decision amongst the respondents. From the one-way analysis of variance, there was no significant difference (p= 0.591) in the mean perception score across occupational status, educational status (P= 0.162) and age groups. An independent-samples t-test showed no significant difference (p=0.287) across gender. The Patients showed satisfaction with care received and expressed that doctor-pharmacist collaboration will reduce medication problems, mistakes/risks as well as improve the quality of care with an expectation that such collaboration is necessary and should be encouraged.

Doctor-pharmacist collaborative role in patient management: perception of patients, doctors and pharmacists

2014

Background: The evolution of pharmacy practice from product-focused to patient-focused orientation is ongoing. Patient care is a complex activity that demands health care professionals to work together in an efficient and effective manner. Collaboration, as a joint communication and decision-making process is based on the belief that quality patient care is achieved by the contribution of expertise from all care providers. Objective: To determine the perception of Patients, Doctors and Pharmacists on doctor-pharmacist collaboration in patient management. Method: A survey using different questionnaires designed to document the perception of respondents on collaboration between doctors and pharmacists. The questionnaires were administered to all the doctors, pharmacists and some patients that consented to participate in the research and SPSS Version 17.0.1 was employed to analyze the obtained data. Results: With a response rate of 98.6%, there was statistical difference in the respond...

Inter-professional collaboration between general practitioners and community pharmacists: general practitioners’ perspectives

2012

The global movement towards enhancing inter-professional collaboration in patient care is in light of the increasing potency of drugs and complexity of drug regimens, particularly in the chronically ill where poly-pharmacy is rife, collaborative patient management by general practitioners and community pharmacists, in particular, has the potential to enhance patient therapeutic outcomes in primary healthcare. Literature from other parts of the world has enumerated the advantages of collaboration. South Africa with its unusual quadruple burden of disease and human resource deficient public healthcare system would benefit from collaboration between general practitioners and community pharmacists through expanded roles for community pharmacists to enable them to make more meaningful contributions to primary healthcare regimens. Particularly with the introduction of the National Health Insurance (NHI) programme. This dissertation aims to assess from general practitioners" perspectives: the current level and stage of collaboration (using the collaborative working relationship (CWR) model proposed by McDonough and Doucette, 2001) between general practitioners and community pharmacists in patient care, if general practitioners" perceptions of the professional roles of community pharmacists in patients" care can influence desired collaboration (prospects of enhanced future collaboration) and how do general practitioners envision enhanced future collaboration between them and community pharmacists in patient care, possible barriers to the envisioned collaboration between the two practitioners, and how general practitioners" iv demographic characteristics influence inter-professional collaboration with community pharmacists. Sixty randomly selected consenting general practitioners in private practice participated in a cross-sectional, face-to-face questionnaire study. The questionnaire contained a range of statements with Likert scale response options. Data was initially entered into Epi Info (version 3.5.1., 2008) and then exported to IBM SPSS Statistical software for analysis (version19, 2010). Medians were used to summarize descriptive data and Spearman"s correlation coefficient, Mann-Whitney U Test and Kruskal-Wallis Test was used for bivariate analysis. Ethical approval was granted by the Senate Research and International Relations Committee, University of the Western Cape (Ethical Clearance Number: 10/4/29). The results indicated low-levels of current collaboration at stage 0 of the CWR model between general practitioners and community pharmacists. A statistically significant correlation was observed between general practitioners" perceptions of the professional roles of community pharmacists and desired collaboration (prospects of enhanced future collaboration), [p=0.0005]. Good prospects of enhanced future collaboration between general practitioners and community pharmacists were observed. General practitioners identified barriers to collaboration to include: the lack of remuneration for collaboration, absence of a government mandate or policy supporting collaboration, inability of general practitioners to share patients" information with community pharmacists and questionable professional ethics exhibited by community pharmacists particularly over financial gains. Most general practitioners agreed that joint continuing professional education organized by pharmaceutical companies or other groups will increase interaction and enhance collaboration. Enhanced Inter-professional collaboration between general practitioners and community pharmacists" can be possible in the future but hindrances need to be eliminated for this to be achieved. Future research can be aimed at exploring the perspectives" of community pharmacists to inter-professional collaboration in South Africa and interventions that will enhance collaboration. v May 2012. vi DECLARATION I declare that Inter-professional Collaboration between General Practitioners' and Community Pharmacists: General Practitioners' Perspectives is my own work, that it has not been submitted before for any degree or examination in any other university, and that all the sources I have used or quoted have been indicated and acknowledged as complete references.

Development and Validation of a Tool to Measure Collaborative Practice Between Community Pharmacists and Physicians From the Perspective of Community Pharmacists: The Professional Collaborative Practice Tool

2021

Background Collaborative practice between community pharmacists and physicians is becoming increasingly common. Although tools and models to explore collaborative practice between both health care professionals have been developed, very few have been validated for their use in clinical practice. The objective of this study was to develop and validate a tool for measuring collaborative practice between community pharmacists and physicians from the perspective of community pharmacists. Methods The DeVellis method was used to develop and validate the Professional Collaborative Practice Tool. A pool of 40 items with Likert frequency scales was generated based on previous literature and expert opinion. A sample of community pharmacists providing medication reviews with follow-up and a random sample of pharmacists providing usual care were invited to participate. Exploratory and confirmatory factor analysis was used to assess the tool’s reliability and content validity. Results 336 pharma...